hCAI/II-IN-6

Overview

hCAI/II-IN-6 is an orally active human carbonic anhydrase ( CA ) inhibitor. hCAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with K i values of 220, 4.9, 6.5 and ＞50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively. hCAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo. hCAI/II-IN-6 can be used for the research of epilepsy.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Carbonic Anhydrase

Product Information

• Catalog No.: HY-148135
• CAS No.: 694466-00-7
• Molecular Formula: C19H24N4O3S
• Molecular Weight: 388.48
• Purity: 98.0%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source